Developing Compelling Global Health Policy Narratives and Supporting Evidence

August 13, 2020

As a part of its global therapeutic area (TA) health policy initiatives, a leading biopharma company needed a new and improved narrative and evidence deck to impress upon policymakers and other critical stakeholders the importance of timely diagnosis and treatment of a specific disease. The materials were structured in three sections:

  1. Making the case for change for policy makers
  2. Giving reasons to believe effective policy solutions are available
  3. Issuing a call to action by policy makers

BTG delivered a senior health policy consultant to analyze the current research and materials to better understand the burden and impact of the disease. The consultant then created a TA-specific health policy narrative for both U.S. and ex-U.S. markets, developed a one-page leave-behind tailored to each market, and built an external evidence deck for presentation at regional franchise meetings.

 

Previous Article
A Rare Disease Specialist Fluent in the Project Location’s Language
A Rare Disease Specialist Fluent in the Project Location’s Language

In an effort to inform its Rare Diseases commercial strategy within a specific country, an F100 pharmaceuti...

Next Article
Project Management Lead for Medical Evidence, Research, and Innovation Team
Project Management Lead for Medical Evidence, Research, and Innovation Team

An F500 biotech company wanted to engage a consultant to work with its medical evidence, research, and inno...

Get our free guide to working with on-demand talent.

Read Now